Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose clarithromycin in relapsed or refractory extranodal marginal zone lymphoma
NCT01516606Phase 2Completed
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clarithromycin in extranodal marginal zone lymphoma (ENMZL). Started Jan 2012; status: completed.
02
Drugs
clarithromycin
03
Conditions
extranodal marginal zone lymphoma (ENMZL)
Beyond the preview
Go deeper on NCT01516606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516606.